Department of Medical Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, China.
BMC Microbiol. 2024 Oct 3;24(1):386. doi: 10.1186/s12866-024-03546-4.
Stutzerimonas nitrititolerans (S. nitrititolerans) is a rare human pathogenic bacterium and has been inadequately explored at the genomic level. Here, we report the first case of carbapenem-resistant S. nitrititolerans isolated from the peritoneal dialysis fluid of a patient with chronic renal failure. This study analyzed the genomic features, antimicrobial resistance, and virulence factors of the isolated strain through whole genome sequencing (WGS).
The bacterial isolate from the peritoneal dialysis fluid was named PDI170223, and preliminary identification was conducted through Matrix-assisted laser desorption ionization/time of flight mass spectrometry (MALDI-TOF MS). WGS of the strain PDI170223 was performed using the Illumina platform, and a phylogenetic tree was constructed based on the 16S rRNA gene sequences. Antimicrobial susceptibility test (AST) was conducted using the TDR-200B2 automatic bacteria identification/drug sensitivity tester.
S. nitrititolerans may emerge as a human pathogen due to its numerous virulence genes, including those encoding toxins, and those involved in flagellum and biofilm formation. The AST results revealed that the strain is multidrug- and carbapenem-resistant. The antimicrobial resistance genes of S. nitrititolerans are complex and diverse, including efflux pump genes and β⁃lactam resistance genes.
The analysis of virulence factors and antimicrobial resistance of S. nitrititolerans provides clinical insight into the pathogenicity and potential risks of this bacterium. It is crucial to explore the mechanisms through which S. nitrititolerans causes diseases and maintains its antimicrobial resistance, thereby contributing to development of effective treatment and prevention strategies.
史特氏固氮单胞菌(S. nitrititolerans)是一种罕见的人类致病菌,其在基因组水平上的研究还不够充分。本研究报告了首例从慢性肾衰竭患者腹膜透析液中分离出的耐碳青霉烯史特氏固氮单胞菌。通过全基因组测序(WGS),对分离株的基因组特征、抗菌药物耐药性和毒力因子进行了分析。
从腹膜透析液中分离出的细菌命名为 PDI170223,采用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)进行初步鉴定。采用 Illumina 平台对 PDI170223 菌株进行 WGS,基于 16S rRNA 基因序列构建系统发育树。采用 TDR-200B2 自动细菌鉴定药敏测试仪进行药敏试验(AST)。
史特氏固氮单胞菌可能由于其众多毒力基因而成为人类病原体,这些基因包括编码毒素的基因以及参与鞭毛和生物膜形成的基因。AST 结果显示该菌株为多药和碳青霉烯类耐药菌。史特氏固氮单胞菌的抗菌药物耐药基因复杂多样,包括外排泵基因和β-内酰胺类耐药基因。
史特氏固氮单胞菌毒力因子和抗菌药物耐药性的分析为该菌的致病性和潜在风险提供了临床见解。探讨史特氏固氮单胞菌致病和维持其抗菌药物耐药性的机制,对于制定有效的治疗和预防策略至关重要。